Cardiac Arrest: Clinical Trials

18 trials for Cardiac Arrest, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 3 recruiting, 2 terminated, 1 unknown. 18 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 318Completed 12, Recruiting 3, Terminated 2, Unknown 1
Phase 23Completed 1, Recruiting 1, Terminated 1

Follow Cardiac Arrest: new trials by email Literature Review of Cardiac Arrest trials Research Report on Cardiac Arrest

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Amiodarone in Shockable Cardiac Arrest
Amiodarone Hydrochloride Injection, Usual Care Protocol - Cardiac Arrest
Phase 3RecruitingOregon Health and Science University5852025-01-012025-12-19
The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients
Phosphocreatine, Placebo - Hypotension, Consciousness, Level Altered
Phase 3RecruitingUniversità Vita-Salute San Raffaele4002024-10-082025-08-06
Surviving PEA in Roanoke (SPEAR) Study
High Calcium, Low Sodium (HCLS) Crystalloid Therapy, High Calcium, High Sodium (HCHS) Crystalloid Therapy - Cardiac Arrest, Pulseless Electrical Activity
Phase 2 / Phase 3RecruitingCarol Bernier3422022-02-162022-03-17
Prophylactic Amiodarone for Shockable Cardiac Arrest
Amiodarone Injection - Cardiac Arrest, Ventricular Arrythmia
Phase 3UnknownWon Young Kim3022021-04-012021-06-21
NSE Ancillary Study of The Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.
NSE dosage "hypothermia arm", NSE dosage "normothermia arm" - Cardiac Arrest, Hypothermia
Phase 3CompletedCentre Hospitalier Departemental Vendee1062016-03-012019-02-25
IL Ancillary Study of the Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.
Inflammatory biomarkers dosage "Hypothermia Arm", Inflammatory biomarkers dosage "Normothermia Arm" - Cardiac Arrest
Phase 3CompletedCentre Hospitalier Departemental Vendee1162016-03-012019-02-25
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
amiodarone, Lidocaine, Normal saline - Cardiac Arrest
Phase 3CompletedUniversity of Washington30242012-05-012017-04-17
Effects of Laryngeal Tube Ventilation on no Flow Time During Out of Hospital Cardiac Arrest
laryngeal tube ventilation and continuous chest compression - Cardiac Arrest
Phase 3CompletedUniversity Hospital, Grenoble842011-03-012012-07-03
Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] Trial
Therapeutic Hypothermia, Therapeutic Normothermia - Cardiac Arrest
Phase 3CompletedUniversity of Michigan2952009-09-012017-09-29
Hemodynamic Efficiency of an Hemodialysis Treatment With High Permeability in Post-resuscitation Shock
hemodialysis with high permeability (HDHP), CVVH - Cardiac Arrest, Sudden Cardiac Death
Phase 3CompletedAssistance Publique - Hôpitaux de Paris382008-11-022025-09-08
Vasopressin, Epinephrine, and Steroids for Cardiac Arrest
Vasopressin, Epinephrine, Methylprednisolone, Hydrocortisone, Standard CPR Protocol with Epinephrine and two Placebos - Cardiac Arrest
Phase 3CompletedUniversity of Athens3002008-09-012016-11-21
Comparing Vasopressin and Adrenaline in Patients With Cardiac Arrest
Adrenaline, Vasopressin - Cardiac Arrest
Phase 3CompletedSingapore General Hospital7272006-03-012017-03-17
Fluid Shifts in Patients Treated With Therapeutic Hypothermia After Cardiac Arrest
HyperHAES vs. RA-solution/NaCl - Cardiac Arrest
Phase 3CompletedHaukeland University Hospital232005-09-012009-05-01
Induction of Mild Hypothermia in Resuscitated Cardiac Arrest Patients
mild hypothermia - Cardiac Arrest
Phase 2 / Phase 3CompletedMedivance, Inc.642004-11-012007-09-11
AutoPulse Assisted Prehospital International Resuscitation Trial (ASPIRE)
AutoPulse, Manual CPR - Cardiac Arrest
Phase 3TerminatedUniversity of Washington18372004-06-012011-01-27
Effect of Early High-dose Epoetin Alfa During Cardiac Arrest (Pilot Study)
Epo-alpha - Resuscitation, Cardiopulmonary
Phase 3CompletedJanssen Cilag S.A.S.202003-11-012011-05-17
Assessing CPR Quality During In-Hospital Cardiac Arrest
investigational monitor/defibrillator with CPR feedback - Cardiac Arrest
Phase 2 / Phase 3TerminatedUniversity of Chicago2002002-12-012013-09-23
Biphasic Defibrillation Study: Trial to Compare Fixed Versus Escalating Energy
Fixed lower-energy defibrillation, Escalating higher-energy defibrillation - Cardiac Arrest
Phase 3CompletedOttawa Hospital Research Institute2212001-03-012025-04-25

Narrower conditions

Heart Arrest (18)  ·  Hypothermia (3)  ·  Diabetes Insipidus (2)  ·  Ventricular Fibrillation (2)  ·  Bradycardia (1)  ·  Consciousness Disorders (1)  ·  Death, Sudden, Cardiac (1)  ·  Edema (1)  ·  Emergencies (1)  ·  Heart Failure (1)  ·  Hypotension (1)  ·  Hypoventilation (1)  ·  Respiratory Insufficiency (1)  ·  Shock (1)  ·  Tachycardia (1)

Broader conditions

Cardiovascular Diseases (18)  ·  Heart Diseases (18)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Pathologic Processes (5)  ·  Signs and Symptoms (4)  ·  Arrhythmias, Cardiac (3)  ·  Body Temperature Changes (3)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Pituitary Diseases (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)

Interventions

Amiodarone (3)  ·  Epinephrine (2)  ·  Hypothermia, Induced (2)  ·  Vasopressins (2)  ·  Arginine Vasopressin (1)  ·  Defibrillators (1)  ·  Diet, Sodium-Restricted (1)  ·  Hydrocortisone (1)  ·  Lidocaine (1)  ·  Methylprednisolone (1)  ·  Phosphocreatine (1)  ·  Renal Dialysis (1)  ·  Saline Solution (1)

Sponsors

Centre Hospitalier Departemental Vendee (2)  ·  University of Washington (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Carol Bernier (1)  ·  Haukeland University Hospital (1)  ·  Janssen Cilag S.A.S. (1)  ·  Medivance, Inc. (1)  ·  Oregon Health and Science University (1)  ·  Ottawa Hospital Research Institute (1)  ·  Singapore General Hospital (1)  ·  University Hospital, Grenoble (1)  ·  University of Athens (1)  ·  University of Chicago (1)  ·  University of Michigan (1)  ·  Università Vita-Salute San Raffaele (1)

Countries

United States (7)  ·  France (4)  ·  Canada (3)  ·  Greece (1)  ·  Italy (1)  ·  Norway (1)  ·  Singapore (1)  ·  South Korea (1)

Top investigators

Jean-Baptiste Lascarrou, MD (2)  ·  Alain Cariou, MD, PhD (1)  ·  Alfred P. Hallstrom, PhD (1)  ·  Carol Bernier, DO (1)  ·  Charis Roussos, MD, PhD (1)  ·  Frank W Moler, MD, MS (1)  ·  Ian Stiell, MD (1)  ·  Joshua Lupton, MD, MPH (1)  ·  Kennon Heard, M.D. (1)  ·  Lance B Becker, MD (1)  ·  Marcus EH Ong, MBBS (1)  ·  Michael Dean, MD, MBA (1)  ·  Myron Weisfeldt, MD (1)

Results publications

PMID 15657323, PMID 16772625, PMID 17241734, PMID 17353443, PMID 18037223, PMID 18504334, PMID 19451846, PMID 19455024, PMID 19854555, PMID 20466215, PMID 20500876, PMID 20935561, PMID 22353644, PMID 23295834, PMID 23842585, PMID 23860985, PMID 25268768, PMID 25913022, PMID 26940987, PMID 27043165, PMID 27737774, PMID 28904070, PMID 29884735, PMID 30572071, PMID 30922934, PMID 30974188, PMID 33301887, PMID 34990764, PMID 38320013, PMID 38320098, PMID 42383826

NIH funding

K23HL173647 (1), U01HL077863 (1), U01HL094339 (1)